Debbarh H S, Cloeckaert A, Zygmunt M S, Dubray G
Laboratoire de Pathologie Infectieuse et d'Immunologie, Institut National de la Recherche Agronomique, Nouzilly, France.
Vet Microbiol. 1995 Apr;44(1):37-48. doi: 10.1016/0378-1135(94)00058-5.
Distinction between Brucella melitensis infected and vaccinated sheep is needed to fully achieve ovine brucellosis eradication in several countries. For this purpose, we probed immunoblots of cytosoluble protein extract (CPE) of the rough (R) B. melitensis strain B115 with sera of Brucella-free, naturally infected, B. melitensis H38 experimentally infected and B. melitensis Rev.1 vaccinated sheep to identify immunogenic Brucella cytosoluble proteins which may lead to the development of more useful diagnostic tests and which may eventually differentiate vaccinated sheep from infected sheep. Brucella-free sheep sera showed IgM antibody reactivity to protein bands between 19 and 92 kDa. The use of conjugate specific for sheep IgG avoided non specific reactivity to all these bands except to the 39 and 50 kDa bands which were still detected in some Brucella-free sheep sera. In sera of B. melitensis H38 experimentally infected sheep, a specific IgG antibody response was observed against proteins of molecular masses of 19, 24, 28, 32, 39, 50 and 54 kDa. These proteins were also variably detected by IgG of sera from naturally infected sheep. Other proteins of 10, 12, 23, 36, 38, 42, 46, 68, 80 and 92 kDa were also detected by the latter sera. In sera from B. melitensis Rev.1 vaccinated sheep, an IgG antibody response was only observed against proteins with molecular masses of 39 and 50 kDa. These results suggest that the 19, 24, 28, 32 and 54 kDa proteins (the first recognized after experimental infection and that provoked a consistent humoral response during natural infection) could be interesting to develop serological tests for differentiating B. melitensis infection from B. melitensis Rev.1 vaccination.
在一些国家,为了全面实现绵羊布鲁氏菌病的根除,需要区分感染了马尔他布鲁氏菌的绵羊和接种过疫苗的绵羊。为此,我们用来自无布鲁氏菌、自然感染、经马尔他布鲁氏菌H38实验感染以及经马尔他布鲁氏菌Rev.1疫苗接种的绵羊的血清,对粗糙型(R)马尔他布鲁氏菌菌株B115的可溶性细胞蛋白提取物(CPE)的免疫印迹进行检测,以鉴定具有免疫原性的布鲁氏菌可溶性蛋白,这些蛋白可能有助于开发更有效的诊断测试,并最终区分接种疫苗的绵羊和感染的绵羊。无布鲁氏菌的绵羊血清对19至92 kDa之间的蛋白条带显示出IgM抗体反应性。使用针对绵羊IgG的共轭物可避免对所有这些条带产生非特异性反应,但39和50 kDa的条带除外,在一些无布鲁氏菌的绵羊血清中仍能检测到这两条带。在经马尔他布鲁氏菌H38实验感染的绵羊血清中,观察到针对分子量为19、24、28、32、39、50和54 kDa的蛋白产生特异性IgG抗体反应。自然感染绵羊的血清IgG也能不同程度地检测到这些蛋白。后者的血清还检测到了其他分子量为10、12、23、36、38、42、46、68、80和92 kDa的蛋白。在经马尔他布鲁氏菌Rev.1疫苗接种的绵羊血清中,仅观察到针对分子量为39和50 kDa的蛋白产生IgG抗体反应。这些结果表明,19、24、28、32和54 kDa的蛋白(实验感染后首先识别的蛋白,并且在自然感染期间引发持续的体液反应)可能有助于开发用于区分马尔他布鲁氏菌感染和马尔他布鲁氏菌Rev.1疫苗接种的血清学检测方法。